Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: murphy9100 who wrote (413)	3/12/1999 11:39:00 AM
From: 5,17,37,5,101,...	Read Replies (3) \| Respond to of 2515

First go to imclone.com ; this should give complete info If that doesn't answer your questions, email the company. They might elaborate. Early approval called fasttrack is allowed by FDA in certain circumstances where drug is shown to have few side effects and to be clearly effective; C225 may be on fasttrack. Information about drugs during approval process is not available to the public. All that sort of info can be found: fda.gov Info about clinical trials: recap.com Helpful articles: infotrieve.com I hope this gets a little further Jackson